May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Macular Pigment Optical Density and Photophobia
Author Affiliations & Notes
  • A.J. Wenzel
    Psychology, University of New Hampshire, Durham, NH
  • K. Fuld
    Psychology, University of New Hampshire, Durham, NH
  • J.M. Stringham
    Ophthalmology, Medical College of Georgia, Augusta, GA
  • Footnotes
    Commercial Relationships  A.J. Wenzel, None; K. Fuld, None; J.M. Stringham, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1293. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Wenzel, K. Fuld, J.M. Stringham; Macular Pigment Optical Density and Photophobia . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1293.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Two carotenoids regularly consumed in the human diet, lutein (L) and zeaxanthin (Z), accumulate in the central retina. Retinal L and Z, collectively referred to as macular pigment (MP), may protect the retina from free radical insult and photostress by acting as antioxidants and a short–wavelength filter. The light filtering properties of MP may also attenuate photophobia (PP)—visual discomfort induced by normal light exposure—for light sources containing short–wavelengths. The aim of this study was twofold: first, to investigate a possible relationship between integrated macular pigment optical density (iMPOD) and PP thresholds for a short–wavelength target relative to a mid– to long–wavelength target; and second, to measure changes in PP thresholds after increasing MPOD with L supplements. Methods: MPOD, determined psychophysically using heterochromatic flicker photometry, was measured at four retinal loci (20’, 30’, 60’ and 120’) with a Macular Metrics® densitometer. Each subject’s MPOD profile was fit with a Lorentzian function and the area under the curve was calculated to yield iMPOD. PP thresholds for two foveal and two parafoveal, 8.2–degree targets were measured using a Maxwellian–view optical system. At both loci, a psychophysical scaling technique was used to measure subjects’ level of discomfort for a short–wavelength broadband (blue) light, which was strongly absorbed by MP, and a mid– to long–wavelength broadband (orange) light, which was not absorbed my MP. For both eccentricities, the relative energy necessary to induce PP for the blue target was subtracted from the energy necessary for the orange target. The foveal value was then subtracted from the parafoveal value to yield a PP ratio. PP ratios and iMPOD were calculated for ten subjects. Repeated measures were obtained for four of these subjects after six weeks and twelve weeks of consuming 60mg of lutein ester supplements per day. Results: PP ratios were positively correlated with iMPOD (Pearson r=0.78, n=10, p=0.008). For subjects consuming L supplements, iMPOD increased about 16% at six weeks and 26% at twelve weeks. According to a randomized block design, iMPOD (F=17.3, p<0.005) and PP ratios (F=10.1, p<0.025) significantly increased from baseline. Conclusions: MP appears to influence PP thresholds for lights containing short–wavelengths.

Keywords: macular pigment • carotenoids/carotenoid binding proteins 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×